Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: Characterization of interactions between Pt(II) complexes and human serum albumin

Author(s)
Andrei Timerbaev, Svetlana S. Aleksenko, Katarzyna Polec-Pawlak, Rafal Ruzik, Olga Semenova, Christian Hartinger, Slawomir Oszwaldowski, Mathea Sophia Galanski, Maciej Jarosz, Bernhard Keppler
Abstract

Characterizing how platinum metallocomplexes bind to human serum albumin (HSA) is essential in evaluating anticancer drug candidates. Using cisplatin as a reference complex, the application of capillary electrophoresis (CE) to reliably assess drug/HSA interactions was validated. Since this complex is small compared to the size of the protein, the binding response could only be recognized when applying CE coupled to a (platinum) metal-specific mode of detection, namely inductively coupled plasma-mass spectrometry (ICP-MS). This coupling allowed for confirmation of a specific affinity of cisplatin and novel Pt complexes to HSA, measurement of the kinetics of binding reactions, and determination of the number of drug molecules attached to the protein. As the cisplatin/HSA molar ratio increased, the reaction rate became faster with a maximum on the kinetic curve appearing at about 50 h of incubation at 20 times excess of cisplatin. The reaction was characterized as a pseudo-first order reaction with the rate constant k = 0.003 min-1 at 37°C. When incubated with a 20-fold excess of cisplatin, HSA bound up to 10 mol of Pt per mol of the protein. This is indicative for a strong metal-protein coordination occurring at several HSA sites other than the only protein cysteine residue. Structural analogs of cisplatin, bearing aminoalcohol ligands, showed comparable protein binding reactivity and stoichiometry but a common equilibrium was not reached even after one week of incubation. Also apparent was a two-step mechanism of the binding reaction. Results demonstrated the suitability of CE-ICP-MS as a rapid assay for high-throughput studying of drug/HSA interactions. Œ 2004 WILEY-VCH Verlag GmbH & Co. KGaA.

Organisation(s)
Department of Inorganic Chemistry
External organisation(s)
Russian Academy of Sciences, Saratov Institute of Radiation, Chemical and Biological Warfare Defense, Warsaw University of Technology, University of Warsaw
Journal
Electrophoresis
Volume
25
Pages
1988-1995
No. of pages
8
ISSN
0173-0835
Publication date
2004
Peer reviewed
Yes
Austrian Fields of Science 2012
1040 Chemistry
Portal url
https://ucrisportal.univie.ac.at/en/publications/5b119de6-dc0f-402e-988f-af9b0f7562aa